Papers
1
Total Citations
7
H-Index
1
About
Lucien Nedzi is a radiation oncologist whose research has advanced the frontiers of stereotactic body radiotherapy (SBRT), particularly for head and neck cancers. His most-cited work, the 2017 paper "Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer," exemplifies his commitment to translating innovative treatment protocols from bench to bedside. This study, with 7 citations, details the rigorous dosimetric and clinical validation of a hypofractionated SBRT regimen for early glottic cancer—a challenging site due to proximity to critical structures like the carotid artery and vocal cords. Nedzi’s contributions lie in demonstrating that highly precise, few-fraction radiation can achieve tumor control while minimizing toxicity, offering a shorter, more convenient alternative to conventional fractionation. His work underscores the importance of phantom-based quality assurance in safely implementing new techniques. While his citation count reflects a focused, early-stage contribution, Nedzi’s research has helped pave the way for broader adoption of SBRT in laryngeal cancer, a field where organ preservation is paramount. For students and researchers, his career illustrates how meticulous translational research can directly impact clinical practice, merging physics, biology, and patient care.
Research Focus
Key Achievements
Top Papers
- 1